afternoon for conference Good Thanks, joining and quarter first Matt. call. XXXX you thank our
take and our of is a a and everyone our COVID-XX the responded like emergency impacted what quarter have how terrible moment we the health into results, to public for company update on how I'd world. around been crisis everyone has a our country Before review truly moving to to PHE or
an and expectations to Medicare's will of on response its impact update our on our COVID-XX PHE provide potential the I Additionally, company.
no As including Symptoms place is the in and across globe. was higher transmission. among COVID-XX further aware, conditions. in XXXX COVID-XX residents with the led illness order and everyone and pandemic from to symptoms ranged distancing medical some in of social reduce governments death virus resulting resulting China practice to spread severe shelter first in chronic with to mild The to late certain quickly older reported have with those including adults very rates mortality identified
healthcare with system, impact treatment patients professionals certain by is to for the the prescribed COVID-XX. therapy Given oxygen respiratory for
in more recovery also believe patients patients global home, an and in oxygen or room effort could hospital. post treatment appropriate to be the stationary allowing to disease by the who severe early concentrators those professionals relief discharge, in progression such the systems making We by portable need healthcare in patients hospital in as be provide thus treated for hospital to prescribed
The reduced emanating mandates direct-to-consumer and channels direct-to-consumer We behaviors believe sales. sales business-to-business was consumer from toward was first the Europe first lower the in in end channel. domestic pandemic, XXXX, for sales by our and including United started the shelter-in-place of lower the in oxygen quarter and COVID-XX reduced and the the partially orders, late impact pandemic sales the quarter, States business-to-business of the concentrators there travel demand within increase quarter. sales offset As to the interest our heightened particularly confidence,
non-contagious in as illnesses non-competitive of XX expansion It through an HME blended would on Act to to is like March the the the signed a other COVID-XX extended to PHE. response rural COVID-XX update Medicare established the March also to providers on all for the announced bid I recently coverage XX/XX provide bid duration rate PHE stimulus respiratory Next, CARES related blended a areas. of non-competitive and areas and rate X, retroactive new for XXXX. XX/XX bill
Furthermore, duration HXNX the lasted effect emergencies in and reference, reduction as is XXXX Medicare lasted that flu of While Zika public to went the be days X, XX, XXXX. outbreak COVID-XX PHE virus XXXX predict, through the impossible sequestration XXX May the XXX health the approximately the approximately a to days. will removed into X% for
consolidating estimate and compared PHE to rate suppliers in the duration established CARES prevent, respond and PHE. April Medicare place also provide Act billion, a modest to reimbursement of to XXXX When for of for Medicare the fund $XX changes, was The to what was COVID-XX for $XXX providers relief which increases billion of on XX, distributed these we COVID-XX the prepare before.
distribution. XXXX. a be XXXX received Human this April we of which distribute XX, Health patient revenues billion These based announced to funds, provide of million distributions on relief all billion Services allocations $X.X supplier, On funding related net payers. Medicare additional $XX remaining across $XX new started and a As funds and April to on the XX, XXXX, will
June Federal XXXX was is X, the In with until that an interim the addition, there comment on period published in Register XXXX. X, final April rule
proposal determining additional patients clinicians home. allow at patient in allow Medicare to needs for respiratory their manage flexibility This treatments would to devices
for allow for We Medicare paperwork the burden proposing PHE, X, system, and COVID-XX such of the on quicker and solely to retroactive the based concentrators March this respiratory products cover is products. the patients' assessment believe reduce other patient setups. XXXX, oxygen clinicians' on could to During the need
believe bidding of Round announced product in April Also, XXXX changes the in remove flexibility, patients, the for facilitate ongoing X, non-invasive the through oxygen XXXX pricing on bidding could the competitive CMS our we from PHE. oxygen. COVID-XX of competitive conversion ventilator announced competitive we Given portable result, concentrators this bidding be summer the program a due not it the these Inogen's And Round to increased announced has as the category business. to still expect was XXXX. CMS rental delay
changes, these all to Given the provide a respiratory in aid COVID-XX providers Medicare's receiving proper as respiratory well by products We increase to the treatment rapid the response much necessary timely as to access to changes financial needed COVID-XX PHE. allow with in minimal we encouraged will manner HME PHE, patients during service these of assistance are believe disruption. patients during and
will greater serve for meet this company our patients' needs addition, demand flexibility our In products. their to and allow our
will actions, place. to in as no However, is we there while how by are we certainty recognize Medicare's these encouraged changes long remain
provide XXXX. first reflecting XXXX of quarter channel. a by our We will the I X.X% generated total now details of revenue first that, revenue of decline around from quarter With $XX.X million,
we first XXXX some quarter component quarter to As the XXXX. and experienced a previously that shortage manufacturing due of on of part Inogen the One challenges disclosed, the fourth impacted GX
our of GX in production earnings midway were announced first XXXX. we through to return the As last able normal the Inogen quarter to we call, One levels of
demand COVID-XX medical PHE, competitive bidding was the uncertainty business-to-business early quarter the for partners to due availability partially and of XXXX. offset in Inogen equipment increased by to in X.X% sales impact the our quarter Round response increase first home One in around the demand in to provider GX oxygen the by XXXX. Domestic to lower on concentrators the XXXX The first compared of from driven $XX.X $XX.X quarter increased primarily million million
limiting referrals. While continue demand concentrators while home early declined there the provider was believe demand traditionally patient our led or COVID-XX to for surge medical oxygen limited an initial partners patient offices physician we that have in oxygen be that in new equipment PHE, for could interactions
associated sales $XX.X as certain first markets, are quarter tenders PHE. Kingdom million Australia. with in increase of the in with million partially continued hold constant International increased in the pending the offset a in in slightly The PHE to reported the quarter primarily Sales down by the and the XXXX. of XXXX uncertainty tender were business-to-business and to The the quarter. COVID-XX currency increased X.X% on X.X% on associated Canada first basis was driven compared on in in European higher to United primarily due $XX.X demand basis demand an by COVID-XX Europe,
the from $XX.X quarter the approximate first beginning the the mandated to of an concentrators sales confidence, of driven population. our in head the reduction decrease sales count initiatives quarter in in from in primarily sales shelter-in-place was year. million decreased March, mobility, of headcount government increase by by across the was which versus first XXXX economic reduced XX% in million and XXXX seasonal for rolled average the in oxygen plans the The resulting X.X% States increase to lack partially to that Reduction prior XXXX. our believe patient representative mobility in offset consumer reduced an decline the tends the comparative be Direct-to-consumer in of remaining period an in from $XX of reps. quarter with combined first among of consumers, particularly a travel United demand. sales slowdown This portable We the productivity
increased our In seasonality approximately first representatives XX% our sales due of the the quarter compared quarter expectations in XXXX dropped April, first to hire typically in volumes we did XXXX. direct-to-consumer volumes new order order by business. when to see to of We
and sales coaching, However, and due for the remote representative plan direct-to-consumer new to challenges the hiring to rates of XXXX. reduce of close reduced training we hiring, remainder
XXXX, of rates. the XXXX million, Medicare first XXXX. as to quarter of X.X% of quarter We in reduction first $X.X the reimbursement higher of approximately on XX,XXX the a by on first the of patients primarily offset due in but partially to of revenue service, Rental decreased decrease X.X% to end had patients service quarter compared a
as setups While intake increased should we sales fourth of patient team. productivity in made rental team count well increased rental to of expanding quarter X.X% to progress as lead compared which inside was down XXXX, our the our
and as coming decreasing $XXX.X stability believe We where independence this adaptable strong service cash we and given of Inogen for today debt oxygen operate future no with we and with the outstanding be during stands level certain global providers. see to us and delivery cash as spite challenges cost in it increased provides worldwide time. the therapy million to equivalents in while of the for of and months, freedom POCs liquidity economy unprecedented also provides patients, still and a patients and Lastly, face the our
Ali? I over the that, to our Bauerlein. turn now CFO, With will Ali call